Epitalon
Longevity & Cellular Aging
CAS
307297-39-8
Observational
A synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly — one of the smallest bioactive peptides studied for anti-aging purposes. Developed by Russian gerontologist Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as a synthetic analog of epithalamin, a polypeptide extract from the bovine pineal gland. The most ambitious claim in the catalog — that a four amino acid peptide can activate telomerase, elongate telomeres, restore pineal melatonin production, and extend lifespan. Three decades of primarily Russian research support a genuine mechanistic case. Western independent replication remains limited. Classified as a research compound in most markets though compounding pharmacy access is evolving in 2026.
Injectable · Nasal
Research Compound
What It Is
Epitalon (Ala-Glu-Asp-Gly) was engineered by Khavinson's team in the 1980s by identifying the minimal active peptide sequence within epithalamin, a pineal gland extract that had shown life-extending properties in animal studies. The tetrapeptide represents the distillation of the pineal gland's bioregulatory signaling into four amino acids. It belongs to a class of compounds Khavinson calls peptide bioregulators, short peptides proposed to modulate gene expression and restore normal tissue function in aging organisms by binding directly to DNA promoter regions. This gene-regulatory mechanism is unusually direct for a peptide and remains the subject of active scientific debate. Most Epitalon research has been conducted at the St. Petersburg Institute, which creates a concentration-of-source limitation that is important context for evaluating the evidence base.
Mechanism of Action
Epitalon's most studied mechanism is telomerase activation. A landmark 2003 paper by Khavinson et al. reported that Epitalon increased telomerase activity approximately 2.4-fold in human fetal fibroblasts and restored telomerase activity in senescent cells. Treated fibroblasts exceeded the Hayflick limit, undergoing more cell divisions than untreated controls while maintaining telomere length. A 2025 study from an independent Western group confirmed that Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity, providing the first meaningful independent replication of this core claim.
The second major mechanism is pineal gland restoration, Epitalon appears to stimulate the pineal gland to produce melatonin, restoring the circadian melatonin rhythm that declines with aging. Since melatonin is a potent antioxidant and circadian regulator, this mechanism has broad downstream implications for sleep quality, oxidative stress, and systemic aging.
Additional mechanisms include epigenetic remodeling, reversal of chromatin aging and histone modulation, and antioxidant pathway upregulation including SOD, NQO1, and catalase. The breadth of proposed mechanisms is consistent with a compound acting at the level of gene expression rather than a specific receptor.
A notable paradox: classic tumor biology associates telomerase activation with increased cancer risk, yet multiple animal studies with Epitalon report reduced tumor incidence including in HER-2/neu breast cancer mouse models. This paradox has not been resolved and represents an important open question in Epitalon research.
Use Cases
Epitalon's primary studied application is longevity and cellular anti-aging. Animal lifespan studies, primarily in mice and fruit flies, have shown statistically significant lifespan extension in Epitalon-treated groups. A study in aging monkeys demonstrated restoration of circadian melatonin rhythms. A small Russian human study showed improved melatonin secretion in elderly patients. These constitute the strongest human data available and are observational in nature.
In the longevity community Epitalon is used in cyclical protocols for telomere maintenance, sleep quality improvement through melatonin restoration, and general cellular anti-aging. It is one of the more academically serious longevity peptides in the catalog given the mechanistic depth of the telomerase activation research.
Antioxidant and DNA protection applications are supported by in vitro data showing reduced oxidative damage and improved genomic stability in aging cells.
All human applications outside the small Russian observational studies should be considered research-grade only. No large-scale Western randomized controlled trials have been completed.
Known Risks
The telomerase activation mechanism raises the most significant theoretical safety concern, telomerase is activated in the majority of human cancers and compounds that upregulate it carry a plausible carcinogenesis risk. This has not been observed in animal studies and some data suggests reduced tumor incidence, creating the paradox noted above. However the human long-term safety data needed to resolve this question definitively does not exist. No significant acute adverse effects have been reported in available studies. The concentration of research from a single Russian institution limits independent safety verification. Research compound only.
Available Forms
Available as a lyophilized sterile powder for reconstitution administered via subcutaneous injection, and as intranasal drops. Injectable is the more commonly used research form given better bioavailability characterization. Research compound only, not available through licensed pharmacies at time of publication. Cyclical administration protocols are common in the research community though no standardized protocol has been established in clinical literature.
Regulatory Status
Research compound in most markets. No FDA or EMA approval for any therapeutic indication. Notable 2026 development — Epitalon is among the peptides being discussed for return to licensed compounding pharmacies following evolving FDA reclassification discussions, which would represent a meaningful regulatory shift. PeptideClear will update this profile as the regulatory situation develops. Not currently available through licensed US compounding pharmacies.
Sources
https://pubmed.ncbi.nlm.nih.gov/12937682/
https://pubmed.ncbi.nlm.nih.gov/15452611/
https://pubmed.ncbi.nlm.nih.gov/12209581/
https://pubmed.ncbi.nlm.nih.gov/40908429/
Similar Compounds
MOTS-c, Humanin, Carnosine, Sermorelin, Tesamorelin
